Cerebral amyloid angiopathy with severe secondary vascular pathology: A histopathological study

Dementia and Geriatric Cognitive Disorders

Volumn 20, Issue 5, 2005, Pages 321-330

  Van Horssen, Jack ^a   De Jong, Danielle ^a   De Waal, Robert M W ^a   Maass, Cathy ^a   Otte Höller, Irene ^a   Kremer, Berry ^a   Verbeek, Marcel M ^a   Wesseling, Pieter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Cerebral amyloid angiopathy; Cerebral hemorrhages; Vascular dementia; Vascular pathology

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN NECROSIS; CELL DEGENERATION; CLINICAL ARTICLE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; MACROPHAGE MIGRATION; MALE; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR AMYLOIDOSIS;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NEURODEGENERATIVE DISEASES; RISK FACTORS;

EID: 26644470375     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088462     Document Type: Article

References (44)

1. Itoh Y, Yamada M: Cerebral amyloid angiopathy in the elderly: the clinicopathological features, pathogenesis, and risk factors. J Med Dent Sci 1997;44:11-19.
2. Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T: Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 1993;16:135-141.
3. Jellinger KA: Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 2002;109:813-836.
4. Vinters HV: Cerebral amyloid angiopathy. A critical review. Stroke 1987;18:311-324.
5. Vinters HV, Wang ZZ, Secor DL: Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 1996;6:179-195.
6. Olafsson I, Grubb A: Hereditary cystatin C amyloid angiopathy. Amyloid 2000;7:70-79.
7. Hund E, Linke RP, Willig F, Grau A: Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment. Neurology 2001;56:431-435.
8. Kiuru S: Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid 1998;5:55-66.
9. Holton JL, Ghiso J, Lashley T, Rostagno A, Guerin CJ, Gibb G, Houlden H, Ayling H, Martinian L, Anderton BH, Wood NW, Vidal R, Plant G, Frangione B, Revesz T: Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 2001;158:515-526.
10. Ghetti B, Piccardo P, Frangione B, Bugiani O, Giaccone G, Young K, Prelli F, Farlow MR, Dlouhy SR, Tagliavini F: Prion protein amyloidosis. Brain Pathol 1996;6:127-145.
11. Glenner GG, Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;20:885-890.
12. Revesz T, Holton JL, Lashley T, Plant G, Rostagno A, Ghiso J, Frangione B: Sporadic and familial cerebral amyloid angiopathies. Brain Pathol 2002;12:343-357.
13. Gilbert JJ, Vinters HV: Cerebral amyloid angiopathy: incidence and complications in the aging brain I. Cerebral hemorrhage. Stroke 1983;14:915-923.
14. Kalyan-Raman UP, Kalyan-Raman K: Cerebral amyloid angiopathy causing intracranial hemorrhage. Ann Neurol 1984;16:321-329.
15. Yamada M: Cerebral amyloid angiopathy: an overview. Neuropathology 2000;20:8-22.
16. Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finklestein SP: The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993;43:2073-2079.
17. Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP: Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991;30:637-649.
18. Mandybur TI: Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol 1986;45:79-90.
19. van Horssen J, Otte-Holler I, David G, Maat-Schieman ML, van den Heuvel LP, Wesseling P, de Waal RM, Verbeek MM: Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. Acta Neuropathol 2001;102:604-614.
20. Vinters HV, Natte R, Maat SM, van Duinen SG, Hegeman K, Welling GC, Haan J, Roos RA: Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol 1998;95:235-244.
21. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
22. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
23. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.
24. Mullan M, Houlden H, Windelspecht M, Fidani L, Lombardi C, Diaz P, Rossor M, Crook R, Hardy J, Duff K: A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat Genet 1992;2:340-342.
25. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
26. Knudsen KA, Rosand J, Karluk D, Greenberg SM: Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001;56:537-539.
27. Mann DM: The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 1988;43:99-136.
28. Roks G, Van Harskamp F, De Koning I, Cruts M, De Jonghe C, Kumar-Singh S, Tibben A, Tanghe H, Niermeijer MF, Hofman A, Van Swieten JC, Van Broeckhoven C, Van Duijn CM: Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Brain 2000;123:2130-2140.
29. Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den Haute C, Mercken M, Moechars D, Laenen I, Kuiperi C, Bruynseels K, Tesseur I, Loos R, Vanderstichele H, Checler F, Sciot R, Van Leuven F: Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol 2000;157:1283-1298.
30. Levy E, Carman MD, Fernandez M, Power MD, Lieberburg I, van Duinen SG, Bots GT, Luyendijk W, Frangione B: Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124-1126.
31. Luyendijk W, Bots GT, Vegter-van der Vlis M, Went LN, Frangione B: Hereditary cerebral haemorrhage caused by cortical amyloid angiopathy. J Neurol Sci 1988;85:267-280.
32. Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM: Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001;49:697-705.
33. Natte R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA, van Duinen SG: Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 2001;50:765-772.
34. Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ: Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 2002;58:1629-1634.
35. Thomas T, McLendon C, Sutton ET, Thomas G: Beta-amyloid-induced cerebrovascular endothelial dysfunction. Ann NY Acad Sci 1997;826:447-451.
36. Van Nostrand WE, Davis-Salinas J, Saporito-Irwin SM: Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders. Ann NY Acad Sci 1996;777:297-302.
37. Davis-Salinas J, Saporito-Irwin SM, Van Nostrand WE: Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J Neurochem 1995;65:931-934.
38. Verbeek MM, de Waal RM, Schipper JJ, Van Nostrand WE: Rapid degeneration of cultured human brain pericytes by amyloid beta protein. J Neurochem 1997;68:1135-1141.
39. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ: Beta-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 1993;90:10836-10840.
40. Gray F, Vinters HV, Le Noan H, Salama J, Delaporte P, Poirier J: Cerebral amyloid angiopathy and granulomatous angiitis: immunohistochemical study using antibodies to the Alzheimer A4 peptide. Hum Pathol 1990;21:1290-1293.
41. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT: Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-259.
42. Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thal JH: Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol 2000;57:869-874.
43. Zarow C, Zaias B, Lyness SA, Chui H: Cerebral amyloid angiopathy in Alzheimer disease is associated with apolipoprotein E4 and cortical neuron loss. Alzheimer Dis Assoc Disord 1999;13:1-8.
44. Greenberg SM, Vonsattel JP, Segal AZ, Chiu RI, Clatworthy AE, Liao A, Hyman BT, Rebeck GW: Association of apolipoprotein E epsilon 2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998;50:961-965.